- Accepting New Patients
- Telehealth Visits
- Insurance plan information
Saul Tapia Ruiz, MD
He | Him | HisFamily Medicine- Accepting New Patients
- Telehealth Visits
- Insurance plan information
Saul Tapia Ruiz, MD
He | Him | HisFamily Medicine- Accepting New Patients
- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Saul Tapia Ruiz is a family medicine doctor who cares for patients of all ages. He has a special interest in preventive medicine, including prevention of HIV and other sexually transmitted infections. For patients with complex needs, he enjoys collaborating with other specialists to ensure comprehensive treatment plans. His approach to daily practice centers on the belief that there is no substitute for taking the time to listen carefully and perform thorough exams.
Tapia Ruiz earned his medical degree from the University of Guanajuato in Mexico. He completed an international medical graduate program at the University of California, Los Angeles and a residency in family medicine at Natividad Medical Center.
Outside of work, Tapia Ruiz enjoys spending time with friends and family, traveling, exploring museums, staying active through hiking and tennis, and appreciating nature.
Education & training
Board certification
- Family Medicine, American Board of Family Medicine
Residency
- Family Medicine, Natividad Medical Center
Internship
- Family Medicine, Harbor / UCLA Medical Center
Degree
- MD, Universidad de Guanajuato
My expertise
Specialties
- Family Medicine
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%224671%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224671%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.